You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

~ Buy the RYTARY (carbidopa; levodopa) Drug Profile, 2024 PDF Report in the Report Store ~

Drug Price Trends for RYTARY


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for RYTARY

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
RYTARY ER 36.25 MG-145 MG CAP 64896-0662-01 3.98184 EACH 2024-06-19
RYTARY ER 48.75 MG-195 MG CAP 64896-0663-01 3.97986 EACH 2024-06-19
RYTARY ER 23.75 MG-95 MG CAP 64896-0661-01 3.98556 EACH 2024-06-19
RYTARY ER 61.25 MG-245 MG CAP 64896-0664-01 5.00630 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for RYTARY

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
RYTARY 61.25MG/245MG CAP Amneal Pharmaceuticals of New York, LLC 64896-0664-01 100 378.27 3.78270 EACH 2023-01-01 - 2027-06-30 FSS
RYTARY 23.75MG/95MG Amneal Pharmaceuticals of New York, LLC 64896-0661-01 100 267.61 2.67610 EACH 2023-01-01 - 2027-06-30 Big4
RYTARY 48.75MG/195MG CAP Amneal Pharmaceuticals of New York, LLC 64896-0663-01 100 301.04 3.01040 EACH 2023-01-01 - 2027-06-30 FSS
RYTARY 36.25MG/145MG CAP Amneal Pharmaceuticals of New York, LLC 64896-0662-01 100 301.04 3.01040 EACH 2023-01-01 - 2027-06-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.